• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    APx Acquisition Corp. I Announces Approval of Extension Meeting Proposals and Intention to Extend Combination Period

    2/27/23 5:05:00 PM ET
    $APXI
    Blank Checks
    Finance
    Get the next $APXI alert in real time by email

    APx Acquisition Corp. I ("APx" or the "Company"), a special purpose acquisition company, announced today that at the extraordinary general shareholders meeting held on February 27, 2023, the Company's shareholders voted in favor of proposals to approve an amendment to the Investment Management Trust Agreement, dated December 6, 2021, and the Company's Amended and Restated Memorandum and Articles of Association (the "Amended Articles of Association") to change the payment required to extend the date by which the Company must consummate an initial business combination (the "Combination Period") by two three-month periods. As amended, the required payments are the deposit by the Company into the trust account (the "Trust Account") established in connection with the Company's initial public offering (the "IPO"), of the lesser of (a) $750,000 and (b) $0.125 for each Class A ordinary share then outstanding for each three month amendment.

    In connection with the vote to approve the proposals, holders of 10,693,417 shares of Class A ordinary shares issued as part of the units sold in the IPO (the "Public Shares") properly exercised their right to redeem their shares (and did not withdraw their redemption) for cash at a redemption price of approximately $10.41 per share, for an aggregate redemption amount of approximately $111,346,281.12. Following such redemptions, approximately $68,271,080.69 will remain in the Trust Account and 6,556,583 Public Shares will remain issued and outstanding.

    On February 27, 2023, the Company's sponsor notified the Company of its intent to extend the Combination Period by one three-month period.

    About APx Acquisition Corp. I

    APx Acquisition Corp. I is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

    Cautionary Note Concerning Forward-Looking Statements

    This press release contains statements that constitute "forward-looking statements," including with respect to the Company's search for an initial business combination. No assurance can be given that the Company will ultimately complete a business combination transaction. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement for the initial public offering and other reports filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230227005904/en/

    Get the next $APXI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APXI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $APXI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    APX Acquisition Corp. I Announces Nasdaq Delisting Notification for Warrants and Units

    NASHVILLE, Tenn., Nov. 1, 2024 /PRNewswire/ -- As previously announced, on September 4, 2024, APX Acquisition Corp. I (NASDAQ: APXI) (the "Company"), received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that since the Company's aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C) (the "Rule"), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the "Notice"). The Company subsequently submitted a plan to regai

    11/1/24 5:48:00 PM ET
    $APXI
    Blank Checks
    Finance

    APX Acquisition Corp. I Reports 10-K Delinquency Notice

    NASHVILLE, Tenn., June 5, 2024 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI) ("Company"), a publicly traded special purpose acquisition company, today announced that it received a deficiency letter (the "Letter") on May 30, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"). The Letter notified the Company that since the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2023 (the "Form 10-K") and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the "Form 10-Q"), the Company does not comply with Nasdaq's Listing Rule 5250(c)(1) relating to the Company's obligation to file periodic financi

    6/5/24 1:33:00 PM ET
    $APXI
    Blank Checks
    Finance

    APx Acquisition Corp. I, OmnigenicsAI Corp and MultiplAI Health Ltd enter into Business Combination Agreement to create a global AI-driven genomics platform

    NASHVILLE, Tenn., March 26, 2024 /PRNewswire/ -- APx Acquisition Corp. I (NASDAQ:APXI) ("APx"), a publicly traded special purpose acquisition company, OmnigenicsAI Corp ("OmnigenicsAI"), a precision medicine company incubated by Bioceres Group PLC, and MultiplAI Health Ltd ("MultiplAI"), a UK-based AI-enabled preventive medicine company, have entered into a definitive Business Combination Agreement ("BCA") that, upon closing, would result in OmnigenicsAI becoming a publicly listed company. The transaction is expected to close mid-year, subject to the approval of APx's shareholders and other customary closing conditions and, upon closing, OmnigenicsAI's shares are expected to be listed on Nas

    3/26/24 8:25:00 AM ET
    $APXI
    Blank Checks
    Finance

    $APXI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Bransfield Kyle P disposed of 100,000 units of Class A ordinary shares and acquired 100,000 units of Class A ordinary shares (SEC Form 4)

    4 - APx Acquisition Corp. I (0001868573) (Issuer)

    7/31/24 9:45:03 PM ET
    $APXI
    Blank Checks
    Finance

    Bransfield Kyle P disposed of 800,000 units of Class A ordinary shares and acquired 800,000 units of Class A ordinary shares (SEC Form 4)

    4 - APx Acquisition Corp. I (0001868573) (Issuer)

    3/25/24 5:00:06 PM ET
    $APXI
    Blank Checks
    Finance

    Bransfield Kyle P converted options into 3,342,188 units of Class A ordinary shares (SEC Form 4)

    4 - APx Acquisition Corp. I (0001868573) (Issuer)

    2/8/24 9:05:08 PM ET
    $APXI
    Blank Checks
    Finance

    $APXI
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by APx Acquisition Corp. I

    SCHEDULE 13G - APx Acquisition Corp. I (0001868573) (Subject)

    1/7/25 4:31:51 PM ET
    $APXI
    Blank Checks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by APx Acquisition Corp. I

    SCHEDULE 13G/A - APx Acquisition Corp. I (0001868573) (Subject)

    1/7/25 11:47:26 AM ET
    $APXI
    Blank Checks
    Finance

    SEC Form 8-K filed by APx Acquisition Corp. I

    8-K - APx Acquisition Corp. I (0001868573) (Filer)

    12/16/24 4:05:25 PM ET
    $APXI
    Blank Checks
    Finance

    $APXI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by APx Acquisition Corp. I

    SC 13G - APx Acquisition Corp. I (0001868573) (Subject)

    11/14/24 8:51:50 PM ET
    $APXI
    Blank Checks
    Finance

    SEC Form SC 13G filed by APx Acquisition Corp. I

    SC 13G - APx Acquisition Corp. I (0001868573) (Subject)

    11/14/24 4:18:23 PM ET
    $APXI
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by APx Acquisition Corp. I

    SC 13G/A - APx Acquisition Corp. I (0001868573) (Subject)

    10/16/24 9:19:30 AM ET
    $APXI
    Blank Checks
    Finance